Iohexol was first listed in Norway and Sweden in 1982. It is a kind of second-generation non-ionic monomeric contrast agent. Iopromide, Iomeprol, etc. Iohexol has low osmotic pressure, low toxicity to the nervous system, low contrast density, and good tolerance. It can be used for angiography, subarachnoid angiography, coronary angiography, spinal cord and femoral joints, urology angiography, and enhanced CT scanning. Etc., is the "gold standard" for evaluating various X-ray contrast agents in the medical community.
The global market for Iohexol API was estimated to be worth US$ 506.1 million in 2023 and is forecast to a readjusted size of US$ 885.3 million by 2030 with a CAGR of 6.9% during the forecast period 2024-2030
Global key manufacturers of Iohexol API include GE Healthcare, Otsuka Chemicals, Starry, etc. Global top three manufacturers hold a share about 85%. Europe is the largest market of Iohexol API, holds a share over 60%. In terms of product, the Original Drug holds a larger segment, with a share over 80%. And in terms of application, the largest application is Hospitals, with a share of over 90%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Iohexol API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Iohexol API by region & country, by Type, and by Application.
The Iohexol API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Iohexol API.
Market Segmentation
By Company
GE Healthcare
Otsuka Chemicals
Justesa Imagen
Starry Pharmaceutical
Haichang Pharmaceutical
Segment by Type:
Original Drug
Generic Drug
Segment by Application
Hospitals
Clinics
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Iohexol API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Iohexol API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Iohexol API in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Iohexol API Product Introduction
1.2 Global Iohexol API Market Size Forecast
1.2.1 Global Iohexol API Sales Value (2019-2030)
1.2.2 Global Iohexol API Sales Volume (2019-2030)
1.2.3 Global Iohexol API Sales Price (2019-2030)
1.3 Iohexol API Market Trends & Drivers
1.3.1 Iohexol API Industry Trends
1.3.2 Iohexol API Market Drivers & Opportunity
1.3.3 Iohexol API Market Challenges
1.3.4 Iohexol API Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Iohexol API Players Revenue Ranking (2023)
2.2 Global Iohexol API Revenue by Company (2019-2024)
2.3 Global Iohexol API Players Sales Volume Ranking (2023)
2.4 Global Iohexol API Sales Volume by Company Players (2019-2024)
2.5 Global Iohexol API Average Price by Company (2019-2024)
2.6 Key Manufacturers Iohexol API Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Iohexol API Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Iohexol API
2.9 Iohexol API Market Competitive Analysis
2.9.1 Iohexol API Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Iohexol API Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Iohexol API as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Original Drug
3.1.2 Generic Drug
3.2 Global Iohexol API Sales Value by Type
3.2.1 Global Iohexol API Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Iohexol API Sales Value, by Type (2019-2030)
3.2.3 Global Iohexol API Sales Value, by Type (%) (2019-2030)
3.3 Global Iohexol API Sales Volume by Type
3.3.1 Global Iohexol API Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Iohexol API Sales Volume, by Type (2019-2030)
3.3.3 Global Iohexol API Sales Volume, by Type (%) (2019-2030)
3.4 Global Iohexol API Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.2 Global Iohexol API Sales Value by Application
4.2.1 Global Iohexol API Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Iohexol API Sales Value, by Application (2019-2030)
4.2.3 Global Iohexol API Sales Value, by Application (%) (2019-2030)
4.3 Global Iohexol API Sales Volume by Application
4.3.1 Global Iohexol API Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Iohexol API Sales Volume, by Application (2019-2030)
4.3.3 Global Iohexol API Sales Volume, by Application (%) (2019-2030)
4.4 Global Iohexol API Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Iohexol API Sales Value by Region
5.1.1 Global Iohexol API Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Iohexol API Sales Value by Region (2019-2024)
5.1.3 Global Iohexol API Sales Value by Region (2025-2030)
5.1.4 Global Iohexol API Sales Value by Region (%), (2019-2030)
5.2 Global Iohexol API Sales Volume by Region
5.2.1 Global Iohexol API Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Iohexol API Sales Volume by Region (2019-2024)
5.2.3 Global Iohexol API Sales Volume by Region (2025-2030)
5.2.4 Global Iohexol API Sales Volume by Region (%), (2019-2030)
5.3 Global Iohexol API Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Iohexol API Sales Value, 2019-2030
5.4.2 North America Iohexol API Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Iohexol API Sales Value, 2019-2030
5.5.2 Europe Iohexol API Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Iohexol API Sales Value, 2019-2030
5.6.2 Asia Pacific Iohexol API Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Iohexol API Sales Value, 2019-2030
5.7.2 South America Iohexol API Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Iohexol API Sales Value, 2019-2030
5.8.2 Middle East & Africa Iohexol API Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Iohexol API Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Iohexol API Sales Value
6.2.1 Key Countries/Regions Iohexol API Sales Value, 2019-2030
6.2.2 Key Countries/Regions Iohexol API Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Iohexol API Sales Value, 2019-2030
6.3.2 United States Iohexol API Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Iohexol API Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Iohexol API Sales Value, 2019-2030
6.4.2 Europe Iohexol API Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Iohexol API Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Iohexol API Sales Value, 2019-2030
6.5.2 China Iohexol API Sales Value by Type (%), 2023 VS 2030
6.5.3 China Iohexol API Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Iohexol API Sales Value, 2019-2030
6.6.2 Japan Iohexol API Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Iohexol API Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Iohexol API Sales Value, 2019-2030
6.7.2 South Korea Iohexol API Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Iohexol API Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Iohexol API Sales Value, 2019-2030
6.8.2 Southeast Asia Iohexol API Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Iohexol API Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Iohexol API Sales Value, 2019-2030
6.9.2 India Iohexol API Sales Value by Type (%), 2023 VS 2030
6.9.3 India Iohexol API Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 GE Healthcare
7.1.1 GE Healthcare Company Information
7.1.2 GE Healthcare Introduction and Business Overview
7.1.3 GE Healthcare Iohexol API Sales, Revenue and Gross Margin (2019-2024)
7.1.4 GE Healthcare Iohexol API Product Offerings
7.1.5 GE Healthcare Recent Development
7.2 Otsuka Chemicals
7.2.1 Otsuka Chemicals Company Information
7.2.2 Otsuka Chemicals Introduction and Business Overview
7.2.3 Otsuka Chemicals Iohexol API Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Otsuka Chemicals Iohexol API Product Offerings
7.2.5 Otsuka Chemicals Recent Development
7.3 Justesa Imagen
7.3.1 Justesa Imagen Company Information
7.3.2 Justesa Imagen Introduction and Business Overview
7.3.3 Justesa Imagen Iohexol API Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Justesa Imagen Iohexol API Product Offerings
7.3.5 Justesa Imagen Recent Development
7.4 Starry Pharmaceutical
7.4.1 Starry Pharmaceutical Company Information
7.4.2 Starry Pharmaceutical Introduction and Business Overview
7.4.3 Starry Pharmaceutical Iohexol API Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Starry Pharmaceutical Iohexol API Product Offerings
7.4.5 Starry Pharmaceutical Recent Development
7.5 Haichang Pharmaceutical
7.5.1 Haichang Pharmaceutical Company Information
7.5.2 Haichang Pharmaceutical Introduction and Business Overview
7.5.3 Haichang Pharmaceutical Iohexol API Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Haichang Pharmaceutical Iohexol API Product Offerings
7.5.5 Haichang Pharmaceutical Recent Development
8 Industry Chain Analysis
8.1 Iohexol API Industrial Chain
8.2 Iohexol API Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Iohexol API Sales Model
8.5.2 Sales Channel
8.5.3 Iohexol API Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
GE Healthcare
Otsuka Chemicals
Justesa Imagen
Starry Pharmaceutical
Haichang Pharmaceutical
*If Applicable.